Henrickson Nauta Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$375K Buy
1,491
+564
+61% +$121K 0.09% 74
2026
Q1
$202K Sell
927
-783
-46% -$174K 0.06% 103
2025
Q4
$383K Buy
1,710
+799
+88% +$182K 0.06% 88
2025
Q3
$211K Buy
+911
New +$186K 0.07% 88
2022
Q1
Sell
-6
Closed -$1K 48
2021
Q4
$1K Buy
+6
New +$709 ﹤0.01% 250

Other funds holding ABBV

Henrickson Nauta Wealth Advisors's ABBV Position: Q2 2026 in Review

Henrickson Nauta Wealth Advisors increased its AbbVie (ABBV) stake by 61% in Q2 2026, buying an estimated $121K and bringing the position to 1,491 shares worth $375K. The position accounts for 0.09% of the portfolio, ranked #74.

Henrickson Nauta Wealth Advisors first reported a position in ABBV in Q4 2021 and has held it in 5 quarters since. The position peaked at $383K in Q4 2025. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Henrickson Nauta Wealth Advisors held 1,491 shares of AbbVie worth $375K as of Q2 2026.
  • Henrickson Nauta Wealth Advisors bought 564 AbbVie shares in Q2 2026, an estimated $121K.
  • AbbVie made up 0.09% of Henrickson Nauta Wealth Advisors's portfolio in Q2 2026, its #74 holding.
  • Henrickson Nauta Wealth Advisors first reported a position in AbbVie in Q4 2021 and has held it in 5 quarters since.
  • Henrickson Nauta Wealth Advisors's AbbVie position peaked at $383K in Q4 2025.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Henrickson Nauta Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.